interesting stuff, seems to be protective using receptor and anti cancer RAS inhibitor mechanism.
No expert but although a currently approved product it’s for blood pressure control, to be used for cancer and in combo with dox would require trials, so being first to market is relevant. Off-label use wouldn’t be a feasible strategy.
RAS inhibitor may be selective and promising anti-cancer in certain cancer indications, you can see the two groups below one performing well and group B (perhaps not impacted by RAS) which was underwhelming anti-cancer and x100 dose of Bisantrene.
Included Bisantrene as a comparative, note the IC50
dosing.
http://dx.doi.org/10.1177/1470320319851310
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
Cardioprotection thread, page-687
-
- There are more pages in this discussion • 219 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.49 |
Change
-0.015(1.00%) |
Mkt cap ! $255.5M |
Open | High | Low | Value | Volume |
$1.50 | $1.51 | $1.49 | $49.15K | 32.80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.50 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18 | 1.490 |
3 | 1825 | 1.480 |
2 | 17265 | 1.475 |
1 | 950 | 1.470 |
2 | 1756 | 1.465 |
Price($) | Vol. | No. |
---|---|---|
1.495 | 500 | 1 |
1.500 | 14604 | 2 |
1.510 | 556 | 1 |
1.515 | 1 | 1 |
1.520 | 45 | 1 |
Last trade - 12.28pm 22/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online